Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention …
GYH Lip, K Huber, F Andreotti… - Thrombosis and …, 2010 - thieme-connect.com
There remains uncertainty over optimal antithrombotic management strategy for patients
with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing …
with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing …
The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review
Purpose Atrial fibrillation (AF) is commonly associated with structural heart disease.
Although heart failure (HF) has been proposed as a risk factor for stroke, the coexistence of …
Although heart failure (HF) has been proposed as a risk factor for stroke, the coexistence of …
Internal carotid artery occlusion: pathophysiology, diagnosis, and management
Abstract Purpose of Review Acute internal carotid artery occlusion (ICAO) is associated with
large infarcts and poor clinical outcomes and contributes to morbidity and mortality …
large infarcts and poor clinical outcomes and contributes to morbidity and mortality …
Predicting left atrial thrombi in atrial fibrillation
WE Wysokinski, N Ammash, F Sobande, H Kalsi… - American heart …, 2010 - Elsevier
BACKGROUND: The aim of the study was to determine whether CHADS2 score is predictive
of left atrial appendage thrombus (LAAT) in nonvalvular atrial fibrillation (AF). Strategies for …
of left atrial appendage thrombus (LAAT) in nonvalvular atrial fibrillation (AF). Strategies for …
Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk'[CHADS2 score= 1]: simplifying stroke risk assessment and …
GYH Lip - Thrombosis and haemostasis, 2010 - thieme-connect.com
Atrial fibrillation (AF) is a common and increasingly important risk factor for stroke and
thromboembolism. However, this risk is not homogeneous, many recognised risk factors …
thromboembolism. However, this risk is not homogeneous, many recognised risk factors …
Indexed left atrial volume is superior to left atrial diameter in predicting nonvalvular atrial fibrillation recurrence after successful cardioversion: a prospective study
P Marchese, V Malavasi, L Rossi… - …, 2012 - Wiley Online Library
Background: Although indexed left atrial volume (iLAV) is the most accurate measure of left
atrial size, it has not been evaluated prospectively as predictor of recurrence of atrial …
atrial size, it has not been evaluated prospectively as predictor of recurrence of atrial …
[PDF][PDF] Thromboembolism associated with atrial fibrillation as a cause of limb and organ ischemia
M Wasilewska, I Gosk-Bierska - Adv Clin Exp Med, 2013 - dbc.wroc.pl
Atrial fibrillation (AF) is associated with a high risk of thromboembolic episodes. Stroke is the
most common embolic complication of AF. Consequently, the majority of the conclusions …
most common embolic complication of AF. Consequently, the majority of the conclusions …
How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation?
S Rietbrock, JM Plumb, AM Gallagher… - Thrombosis and …, 2009 - thieme-connect.com
The objective of this study was to evaluate the rate of stroke associated with aspirin and
warfarin in routine clinical practice. The study included patients aged 40+ with chronic atrial …
warfarin in routine clinical practice. The study included patients aged 40+ with chronic atrial …
Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis
GYH Lip - Thrombosis and haemostasis, 2008 - thieme-connect.com
A trial fibrillation (AF) is the commonest sustained cardiac rhythm disorder, which has
particularly attracted much clinical and research interest from the mortality and morbidity …
particularly attracted much clinical and research interest from the mortality and morbidity …
Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With …
BJ Geller, RP Giugliano, E Braunwald, SA Murphy… - American Heart …, 2015 - Elsevier
Background Atrial fibrillation (AF) is a major risk factor for stroke and systemic embolism.
Trials comparing warfarin with non–vitamin K oral anticoagulants (NOACs) have …
Trials comparing warfarin with non–vitamin K oral anticoagulants (NOACs) have …